16 - 29 January 2021
These are links to recent news stories about multiple sclerosis that may be of interest to people affected by MS in the UK. The link beneath each item will take you to the original story.
Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.
To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter, or regular email alerts.
NICE turn down ozanimod
Ozanimod (Zeposia), a new drug for relapsing MS, has not been approved for the NHS in England following a decision by NICE. The drug didn't meet their cost effectiveness threshold and its effect on progression was unclear. A consultation on the decision runs until 12 February
Stem cell treatment effective over ten years
AHSCT (autologous hematopoietic stem cell transplantation) stops disability progression in most people with MS according to an Italian study that followed people for up to ten years. A greater effect was seen in people with relapsing MS
Warning of fake Covid vaccine invitations
Natalie's MS journey and how it led to the Black MS Foundation, by Natalie
18 Jan 2022 - 00:00
We caught up with Natalie, Founder of the Black MS Foundation to hear about her multiple sclerosis journey and find out what led her to set up the Foundation.
MS and exercise: part one - a Q&A with physiotherapist, Henriette
14 Jan 2022 - 00:00
In this first blog in a new series, we talk to physiotherapist, Henriette who answers some common questions people with MS may have about exercising.
New study provides strong evidence for role of Epstein Barr virus as a trigger for multiple sclerosis
14 Jan 2022 - 00:00
New research has provided evidence that infection with the Epstein Barr virus acts as a trigger for people to develop MS.
Sign up for updates from us
Keep up-to-date with the latest MS news, explore new research, read the stories of people living with MS, find out practical tips from MS experts, and discover exciting fundraising opportunities.